We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+6.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.1B
AUM Growth
+$1.81B
(+5.1%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
8.75%
Holding
2,506
New
326
Increased
944
Reduced
921
Closed
286
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$297M |
| 2 |
CELG
Celgene Corp
CELG
|
+$277M |
| 3 |
US Bancorp
USB
|
+$190M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$259M |
| 2 |
DuPont de Nemours
DD
|
+$255M |
| 3 |
Boeing
BA
|
+$243M |
| 4 |
Altria Group
MO
|
+$234M |
| 5 |
Union Pacific
UNP
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.5% |
| 2 | Technology | 15.03% |
| 3 | Consumer Discretionary | 14.19% |
| 4 | Industrials | 12.34% |
| 5 | Consumer Staples | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Tilly's
TLYS
$115M
| $2.72M | 0.01% |
184,570
+2,100
| +1% | +$28.2K |
|
1102
Plexus
PLXS
$6.81B
| $2.72M | 0.01% |
44,825
-68,500
| -60% | -$4.15M |
|
1103
Regis Corp
RGS
$69.9M
| $2.72M | 0.01% |
8,861
-1,785
| -17% | -$548K |
|
|
RDC
1104
DELISTED
Rowan Companies Plc
RDC
| $2.72M | 0.01% |
173,777
-135,200
| -44% | -$1.9M |
|
1105
Axos Financial
AX
$5.45B
| $2.71M | 0.01% |
90,669
+14,400
| +19% | +$392K |
|
|
GOOD
1106
Gladstone Commercial Corp
GOOD
$627M
| $2.71M | 0.01% |
128,725
-51,039
| -28% | -$1.13M |
|
1107
United Therapeutics
UTHR
$26.3B
| $2.7M | 0.01% |
18,273
+15,402
| +536% | +$1.96M |
|
1108
Entravision Communication
EVC
$983M
| $2.7M | 0.01% |
377,800
+243,900
| +182% | +$1.53M |
|
1109
Community Health Systems
CYH
$385M
| $2.7M | 0.01% |
633,012
-138,560
| -18% | -$696K |
|
|
FIT
1110
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $2.69M | 0.01% |
471,257
+305,421
| +184% | +$1.94M |
|
1111
Healthpeak Properties
DOC
$15.4B
| $2.67M | 0.01% |
102,444
-608,382
| -86% | -$16.1M |
|
|
JHG
1112
DELISTED
Janus Henderson
JHG
| $2.67M | 0.01% |
+69,809
| New | +$2.52M |
|
1113
Central Pacific Financial
CPF
$997M
| $2.66M | 0.01% |
89,176
+9,000
| +11% | +$281K |
|
1114
Tetra Tech
TTEK
$8.23B
| $2.65M | 0.01% |
275,535
-23,000
| -8% | -$223K |
|
|
CLDT
1115
Chatham Lodging
CLDT
$630M
| $2.64M | 0.01% |
115,985
+92,903
| +402% | +$2.08M |
|
|
LTRPA
1116
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $2.62M | 0.01% |
278,300
-35,900
| -11% | -$369K |
|
|
VSA
1117
VisionSys AI
VSA
$9.61M
| $2.62M | 0.01% |
70
+24
| +52% | +$857K |
|
1118
Andersons Inc
ANDE
$2.65B
| $2.62M | 0.01% |
84,018
-11,739
| -12% | -$391K |
|
1119
Buckle
BKE
$2.19B
| $2.61M | 0.01% |
110,000
+8,300
| +8% | +$164K |
|
1120
Hyster-Yale Materials Handling
HY
$593M
| $2.61M | 0.01% |
30,668
-200
| -0.6% | -$16.5K |
|
|
ARGO
1121
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $2.6M | 0.01% |
48,540
+13,181
| +37% | +$706K |
|
|
EGIO
1122
DELISTED
Edgio, Inc. Common Stock
EGIO
| $2.6M | 0.01% |
14,734
+8,825
| +149% | +$1.74M |
|
|
INWK
1123
DELISTED
InnerWorkings, Inc.
INWK
| $2.6M | 0.01% |
258,799
+91,400
| +55% | +$981K |
|
1124
McGrath RentCorp
MGRC
$2.94B
| $2.59M | 0.01% |
55,202
-7,600
| -12% | -$352K |
|
|
CADE
1125
DELISTED
Cadence Bancorporation
CADE
| $2.59M | 0.01% |
+95,500
| New | +$2.3M |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, Two Sigma Advisers held 2,506 positions worth $37.1B, up 5.1% from $35.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Two Sigma Advisers's Q4 2017 filing shows 326 new, 944 increased, 921 reduced and 286 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 381,038 shares worth $143M. The largest sale was Chevron, an estimated $259M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
- Two Sigma Advisers's largest Q4 2017 buy was Regeneron Pharmaceuticals: 381,038 shares worth $143M.
- Two Sigma Advisers added most to PG&E in Q4 2017, an estimated $297M increase.
- Two Sigma Advisers's biggest Q4 2017 reduction was Chevron, cutting an estimated $259M.
- Two Sigma Advisers fully exited DuPont de Nemours in Q4 2017, selling an estimated $255M.
- Two Sigma Advisers's ten largest holdings make up 8.7% of its $37.1B portfolio in Q4 2017.
- Two Sigma Advisers opened 326 new positions and closed 286 in Q4 2017.
- Two Sigma Advisers's portfolio value rose 5.1% quarter-over-quarter to $37.1B.
Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.